Squarepoint Ops »

Taysha Gene Therapies shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2023-12-31 $112k 64k 1.77
2023-09-30 $90k 29k 3.16
2023-06-30 $53k 81k 0.66
2021-12-31 $340k 29k 11.64

More positions owned by Squarepoint Ops

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Pdd Holdings Sponsored Ads (PDD)
Amazon Call Option (AMZN)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
Royal Caribbean Cruises (RCL)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Squarepoint Ops

Top funds holding Taysha Gene Therapies

RA Capital Management
VR Adviser
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Point72 Asset Management
Citadel Advisors
T. Rowe Price Associates
Schonfeld Strategic Advisors
Exome Asset Management
Alphabet
Quantum Private Wealth
Palo Alto Investors

View all funds holding Taysha Gene Therapies